Back to companies

BioNote, Inc.

377740KRKRX

바이오노트

Revenue
₩102.8bn
FY2024
Operating income
₩12.2bn
FY2024
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)